Related Experiment Video
Updated: Jun 9, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Quantitating antibody uptake in vivo: conditional dependence on antigen expression levels
Greg M Thurber1, Ralph Weissleder
1Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Antibody uptake in tumors depends on antigen levels when doses saturate binding sites, but is limited by delivery when doses are low. This finding aids in designing better cancer therapies and imaging probes.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Antibodies are crucial cancer therapeutics and imaging agents.
- Discrepancies exist regarding the impact of antigen expression levels on antibody tumor uptake.
Purpose of the Study:
- To investigate the effect of antigen expression level on the tumoral uptake of high-affinity antibodies in vivo.
- To validate a mathematical model predicting antibody uptake.
Main Methods:
- In vivo imaging of fluorescent antibodies in a mouse xenograft model with varying antigen expression.
- Utilized a mathematical model to analyze antibody-tumor interactions.
Main Results:
- Under subsaturating conditions, antibody uptake is limited by vascular delivery, not antigen expression.
- At saturating doses, antibody uptake correlates with the number of available antigen binding sites.
- Smaller micrometastases showed higher antibody targeting than larger tumors.
Conclusions:
- Antibody uptake is dependent on antigen expression for saturating doses and on delivery for subsaturating doses.
- Understanding the balance between biomarker expression and transport is critical for quantitative imaging.
- The predictive model supports the design of more effective antibody-based cancer therapies and imaging probes.
More Related Videos
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018